Pharmacological inhibitors of cyclin-dependent kinases
Top Cited Papers
- 1 September 2002
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 23 (9) , 417-425
- https://doi.org/10.1016/s0165-6147(02)02071-0
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Intracellular Targets of PaullonesJournal of Biological Chemistry, 2002
- Designing Inhibitors of Cyclin-Dependent KinasesAnnual Review of Pharmacology and Toxicology, 2002
- Protein kinases — the major drug targets of the twenty-first century?Nature Reviews Drug Discovery, 2002
- A Novel Approach for the Development of Selective Cdk4 Inhibitors: Library Design Based on Locations of Cdk4 Specific Amino Acid ResiduesJournal of Medicinal Chemistry, 2001
- To cycle or not to cycle: a critical decision in cancerNature Reviews Cancer, 2001
- Structure-Based Generation of a New Class of Potent Cdk4 Inhibitors: Newde NovoDesign Strategy and Library DesignJournal of Medicinal Chemistry, 2001
- The Cyclin-Dependent Kinase (CDK) Inhibitor Flavopiridol Inhibits Glycogen PhosphorylaseArchives of Biochemistry and Biophysics, 2001
- Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitorsChemistry & Biology, 2000
- Cyclin-Dependent Kinase Inhibitors: Useful Targets in Cell Cycle RegulationJournal of Medicinal Chemistry, 2000
- Identification of cytosolic aldehyde dehydrogenase 1 from non‐small cell lung carcinomas as a flavopiridol‐binding proteinFEBS Letters, 1999